**Question of the week** Vertebroplasty

This week, the New England Journal of Medicine compared Vertebroplasty to a placebo procedure. How much does this hurt the VCF market and in particular the companies developing vertebroplasty products? Inquiring minds want to know…

Josh Sandberg

Josh Sandberg is the President of Ortho Spine Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button